Courier Capital LLC lowered its stake in shares of Colgate-Palmolive (NYSE:CL) by 5.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 14,300 shares of the company’s stock after selling 825 shares during the period. Courier Capital LLC’s holdings in Colgate-Palmolive were worth $1,187,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors also recently bought and sold shares of the company. Raymond James Financial Services Advisors Inc. increased its position in shares of Colgate-Palmolive by 4.5% in the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 209,837 shares of the company’s stock valued at $15,373,000 after acquiring an additional 9,057 shares during the period. Marino Stram & Associates LLC purchased a new stake in Colgate-Palmolive in the second quarter valued at $360,000. Valeo Financial Advisors LLC lifted its position in Colgate-Palmolive by 3.4% in the second quarter. Valeo Financial Advisors LLC now owns 4,128 shares of the company’s stock valued at $302,000 after acquiring an additional 135 shares during the last quarter. Patten Group Inc. lifted its position in Colgate-Palmolive by 1.1% in the second quarter. Patten Group Inc. now owns 17,249 shares of the company’s stock valued at $1,264,000 after acquiring an additional 185 shares during the last quarter. Finally, Belpointe Asset Management LLC lifted its position in Colgate-Palmolive by 6.7% in the second quarter. Belpointe Asset Management LLC now owns 3,464 shares of the company’s stock valued at $254,000 after acquiring an additional 218 shares during the last quarter. Institutional investors own 76.74% of the company’s stock.
NYSE CL opened at $85.93 on Tuesday. Colgate-Palmolive has a 12 month low of $58.49 and a 12 month high of $85.94. The company has a debt-to-equity ratio of 6.50, a current ratio of 0.97 and a quick ratio of 0.62. The company has a market capitalization of $73.66 billion, a price-to-earnings ratio of 27.45, a price-to-earnings-growth ratio of 4.60 and a beta of 0.57. The company’s fifty day moving average price is $80.06 and its two-hundred day moving average price is $75.57.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Wednesday, November 4th. The company reported $0.79 EPS for the quarter, beating the Zacks’ consensus estimate of $0.70 by $0.09. Colgate-Palmolive had a net margin of 16.65% and a return on equity of 383.88%. The firm had revenue of $4.15 billion for the quarter, compared to the consensus estimate of $4 billion. During the same period in the prior year, the firm posted $0.71 EPS. The firm’s revenue was up 5.7% compared to the same quarter last year. As a group, analysts anticipate that Colgate-Palmolive will post 3.05 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Monday, November 16th. Shareholders of record on Friday, October 23rd were paid a dividend of $0.44 per share. The ex-dividend date was Thursday, October 22nd. This represents a $1.76 dividend on an annualized basis and a yield of 2.05%. Colgate-Palmolive’s dividend payout ratio (DPR) is 62.19%.
In other news, Director John T. Cahill sold 5,583 shares of the firm’s stock in a transaction dated Wednesday, November 4th. The shares were sold at an average price of $85.31, for a total value of $476,285.73. Following the transaction, the director now directly owns 28,594 shares in the company, valued at approximately $2,439,354.14. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, VP Philip G. Shotts sold 401 shares of the firm’s stock in a transaction dated Monday, September 28th. The stock was sold at an average price of $77.29, for a total transaction of $30,993.29. Following the completion of the transaction, the vice president now owns 41,263 shares in the company, valued at $3,189,217.27. The disclosure for this sale can be found here. Insiders have sold a total of 229,513 shares of company stock worth $19,475,231 over the last quarter. 0.78% of the stock is currently owned by insiders.
A number of research analysts have commented on the stock. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Colgate-Palmolive from $75.00 to $78.00 and gave the company a “hold” rating in a research note on Monday, August 3rd. TheStreet upgraded shares of Colgate-Palmolive from a “c+” rating to a “b+” rating in a research note on Friday, July 31st. Truist lifted their price objective on shares of Colgate-Palmolive from $80.00 to $85.00 in a research note on Monday, October 26th. Royal Bank of Canada lifted their price objective on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the company an “outperform” rating in a research note on Monday, November 2nd. Finally, UBS Group boosted their price target on shares of Colgate-Palmolive from $85.00 to $90.00 and gave the stock a “buy” rating in a research note on Monday, November 2nd. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating and seven have given a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of $78.08.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment products include toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other similar items.
Further Reading: G-20
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.